Article info
PDFCorrespondence
Correspondence on ‘Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients’
- Correspondence to Dr Tanaz A Kermani, Rheumatology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA 90095, USA; tkermani{at}mednet.ucla.edu
Citation
Correspondence on ‘Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients’
Publication history
- Received January 10, 2021
- Accepted January 12, 2021
- First published January 21, 2021.
Online issue publication
September 19, 2023
Article Versions
- Previous version (21 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage